Zurich Cantonal Bank
STOK icon

Zurich Cantonal Bank’s Stoke Therapeutics STOK Stock Holding History

Zurich Cantonal Bank’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Buy
15,238
+5,656
+59% +$182K ﹤0.01% 1938
2026
Q1 		$312K Buy
9,582
+453
+5% +$14.9K ﹤0.01% 2075
2025
Q4 		$290K Hold
9,129
– – ﹤0.01% 2072
2025
Q3 		$215K Hold
9,129
– – ﹤0.01% 2159
2025
Q2 		$104K Hold
9,129
– – ﹤0.01% 2373
2025
Q1 		$60.7K Hold
9,129
– – ﹤0.01% 2496
2024
Q4 		$101K Hold
9,129
– – ﹤0.01% 2432
2024
Q3 		$112K Hold
9,129
– – ﹤0.01% 2379
2024
Q2 		$123K Buy
+9,129
New +$123K ﹤0.01% 2293
2022
Q1 		– Sell
-901
Closed -$22K – 2834
2021
Q4 		$22K Sell
901
-94
-9% -$2.24K ﹤0.01% 2851
2021
Q3 		$25K Sell
995
-9
-0.9% -$251 ﹤0.01% 2766
2021
Q2 		$34K Buy
1,004
+52
+5% +$1.84K ﹤0.01% 2528
2021
Q1 		$37K Buy
+952
New +$54.2K ﹤0.01% 2466

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Zurich Cantonal Bank's STOK Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Stoke Therapeutics (STOK) stake by 59% in Q2 2026, buying an estimated $182K and bringing the position to 15,238 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

Zurich Cantonal Bank first reported a position in STOK in Q1 2021 and has held it in 13 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Zurich Cantonal Bank held 15,238 shares of Stoke Therapeutics worth $499K as of Q2 2026.
  • Zurich Cantonal Bank bought 5,656 Stoke Therapeutics shares in Q2 2026, an estimated $182K.
  • Stoke Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1938 holding.
  • Zurich Cantonal Bank first reported a position in Stoke Therapeutics in Q1 2021 and has held it in 13 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.